Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of 2010-2011 Seasonal Influenza Vaccine in Pregnant Women
NCT01173211Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2010
- Primary completion
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Fluarix, influenza vaccine and Fluzone Trivalent in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoints: Number of Participants Reporting Vaccine-associated Unsolicited Non-serious Adverse Events, Number of Participants Reporting Maternal Complications of Pregnancy, Labor and Delivery and 8 more. Started Sep 2010; status: completed.
02
Drugs
Fluarixinfluenza vaccineFluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01173211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173211.